Predictors of pacemaker implantation within three months after catheter ablation of atrial fibrillation

Author:

Guo Yi1,Chen Hongwu1ORCID,Yang Shu1,Gu Kai1,Shen Youmei1,Ju Weizhu1,Yang Gang1,Shi Jiaojiao1,Wang Zidun1,Liu Hailei1,Jiang Xiaohong1,Chen Minglong1ORCID,Li Mingfang1ORCID

Affiliation:

1. Division of Cardiology The First Affiliated Hospital of Nanjing Medical University Nanjing China

Abstract

AbstractBackgroundIt is inevitable for patients to have a temporary or permanent pacemaker implanted during or after radiofrequency catheter ablation (RFCA) for treatment of atrial fibrillation (AF) in some cases. The aim of our study was to evaluate the incidence of pacemaker implantation (PMI) during or within 3 months of RFCA for AF and to identify the risk factors that were associated with PMI.MethodsWe performed a retrospective analysis of consecutive AF patients who underwent RFCA between August 2018 and October 2020 at our center. The incidence of PMI within 3 months during or after RFCA were assessed. A multivariate logistic regression model was performed to identify predictors of PMI.ResultsOne thousand and five patients (mean age, 60.2 ± 10.3 years; 37.6% women) were included in this analysis. PVI was performed in all patients. A total of 23 (2.3%) patients had a pacemaker implanted within 3 months during or after ablation. Multivariable logistic regression analysis revealed that older age (OR: 1.08 [95% CI 1.03‐1.13], p = .003), female sex (OR: 3.08 [95% CI 1.28‐7.45], p = .012), paroxysmal AF (OR: 4.71 [95% CI 1.09‐20.45], p = .038) and repeated ablation (OR: 2.78 [95% CI 1.04‐7.40], p = .041) were the independent predictors for PMI.ConclusionsOlder age, female sex, paroxysmal AF and repeated ablation were identified as predictive risk factors for PMI after RFCA in patients with AF. A "watch and wait" strategy could be taken for patients with temporary PMI after ablation, especially for those with prolonged sinus pause after AF termination.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3